Dr. Teng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2002 - 2005
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 2001 - 2002
- University of California San Diego School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2002 - 2026
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease Start of enrollment: 2014 Jan 20
- Nicotinamide as an Early Alzheimer's Disease Treatment Start of enrollment: 2017 Jul 12
Publications & Presentations
PubMed
- Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease.Joshua D Grill, Steven Tam, Gaby Thai, Beatriz Vides, Aimee L Pierce
Neurology. 2025-01-14 - 1 citationsPharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.Stephen P Schauer, Balazs Toth, Julie Lee, Lee A Honigberg, Vidya Ramakrishnan
Alzheimer's & Dementia. 2024-11-08 - CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.Cosme Sandoval, Julie Lee, Balazs Toth, Rajini Nagaraj, Stephen P Schauer
Alzheimer's & Dementia. 2024-11-01
Journal Articles
- Prevalence of Amyloid‐Β Pathology in Distinct Variants of Primary Progressive AphasiaGil D Rabinovici, William Seeley, Edmond Teng, David J Irwin, David A Wolk, Annals of Neurology
Press Mentions
- Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
- Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: